Fri, 26th Aug 2016 11:13
LONDON (Alliance News) - Hikma Pharmaceuticals PLC Friday said Non-Executive Director Ronald Goode bought 2,000 shares at a price of 2,180 pence per share on Thursday
Following this transaction, Goode now holds 12,000 shares in the drugmaker.
The stock was up 1.2% at 2,176.00p Friday.
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2016 Alliance News Limited. All Rights Reserved.
(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday:
(Sharecast News) - Citi lifted its price target on Hikma Pharmaceuticals on Tuesday to 2,845p from 2,770p as it said IQVIA April data highlighted "hea...
(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...
Hikma Pharmaceuticals (HIK)